Download PDF
Thromb Haemost 1997; 78(01): 013-023
DOI: 10.1055/s-0038-1657494
Thrombosis in the young
Schattauer GmbH Stuttgart

Cerebrovascular Disease in Young Patients

James Grotta
Stroke Program, University of Texas Medical School Houston, Fannin, Houston, TX, USA
› Author Affiliations
Further Information

Publication History

Publication Date:
12 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Grotta JC. Current medical and surgical therapy for cerebrovascular disease. New Engl J Med 1987; 317: 1505-1516
    CrossrefPubMedGoogle Scholar
  • 2 Adams HP, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Stroke 1993; 24: 35-41
    CrossrefPubMedGoogle Scholar
  • 3 Dusser A, Goutieres G, Aicardi H. Ischemic strokes in children. J Child Neurol 1: 131 1986;
    CrossrefPubMedGoogle Scholar
  • 4 Barmada MA, Moosy J, Shuman RM. Cerebral infarcts with arterial occlusion in neonates. Ann Neurol 6: 495 1979;
    CrossrefPubMedGoogle Scholar
  • 5 Levene M. Current Reviews in Paediatrics. Neonatal Neurology. Vol 03. Churchill Livingstone; New York: 1987
    Google Scholar
  • 6 Lanska MJ, Lanska DJ, Horwitz SJ, Aram DM. Presentation, clinical course, and outcome of childhood stroke. Pediatr Neurol 7: 333 1991;
    CrossrefPubMedGoogle Scholar
  • 7 Roessman U, Miller RT. Thrombosis of the middle cerebral artery associated with birth trauma. Neurology 30: 889 1980;
    CrossrefPubMedGoogle Scholar
  • 8 Jackson AC, Boughner DR, Barnett HJM. Mitral valve prolapse and cerebral ischemic events in young patients. Neurology 34: 784 1984;
    CrossrefPubMedGoogle Scholar
  • 9 Packer RJ, Rorke LB, Lange BJ. et al Cerebrovascular accidents in children with cancer. Pediatrics 76: 194 1985;
    PubMedGoogle Scholar
  • 10 Huttenlocher PR, Mohr JW, Johns L. Cerebral blood flow in sickle cell cerebrovascular disease. Pediatrics 73: 615 1984;
    PubMedGoogle Scholar
  • 11 Pavlakis SG, Phillips PC, Di Mauro S. et al Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol 16: 481 1984;
    CrossrefPubMedGoogle Scholar
  • 12 Whisnant JP. Effectiveness versus efficacy of treatment of hypertension for stroke prevention. Neurology 1996; 46: 301-307
    CrossrefPubMedGoogle Scholar
  • 13 Scandinavian Simvastatin Survival Study Group Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin survival study (4S). The Lancet 1994; 344: 1383-1389
    PubMed
  • 14 Bronner LL, Kanter DS, and Manson JE. Primary prevention of stroke. New Engl J Med 1995; 333: 1392-1399
    CrossrefPubMedGoogle Scholar
  • 15 Levine SR, Brust JCM, Futrell N. et al A comparative study of the cerebrovascular complications of cocaine: Alkaloidal versus hydrochloride -a review. Neurology 1991; 41: 1173-1177
    CrossrefPubMedGoogle Scholar
  • 16 Gorelick PB. Stroke prevention: An opportunity for efficient utilization of health care resources during the coming decade. Stroke 1994; 25: 220-224
    CrossrefPubMedGoogle Scholar
  • 17 Howard G, Anderson R, Sorlie P. et al Ethnic differences in stroke mortality between non-Hispanic whites, Hispanic whites and blacks. Stroke 1994; 25: 2120-2125
    CrossrefPubMedGoogle Scholar
  • 18 Morgenstern LB, Spears WD, Goff DC. et al African Americans and women have the highest stroke mortality in Texas. Stroke. 1997. (in press)
    Google Scholar
  • 19 Clarke R, Kaly L, Robinson K. et al Hyperhomocysteinemia: An independent risk factor for vascular disease. New Engl J Med 1991; 324: 1149-1155
    CrossrefPubMedGoogle Scholar
  • 20 Schievink WI, Michels VV, and Piepgras DG. Neurovascular manifestations of heritable connective tissue disorders. A review. Stroke 1994; 25: 889-903
    CrossrefPubMedGoogle Scholar
  • 21 North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. New Engl J Med 1991; 325: 445-452
    CrossrefPubMedGoogle Scholar
  • 22 European Carotid Surgery Trialists’ Collaborative Group. Endarterectomy for moderate symptomatic carotid stenosis: Interim results from the MRC European Carotid Surgery Trial. The Lancet 1991; 337: 1235-1243
    CrossrefPubMedGoogle Scholar
  • 23 Eliasziw M, Streifler JY, Fox AJ. et al Significance of plaque ulceration in symptomatic patients with high-grade carotid stenosis. Stroke 1994; 25: 304-308
    CrossrefPubMedGoogle Scholar
  • 24 Executive Committee of the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995; 273: 1421-1428
    CrossrefPubMedGoogle Scholar
  • 25 Hobson RW, Weiss DG, Fields WS. et al Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. New Engl J Med 1993; 328: 221-228
    CrossrefPubMedGoogle Scholar
  • 26 The CASANOVA Study Group. Carotid surgery versus medical therapy in asymptomatic carotid stenosis. Stroke 1991; 22: 1229-1235
    CrossrefPubMedGoogle Scholar
  • 27 Higashida RT, Tsai FY, Halbach VV. et al Transluminal angioplasty for atherosclerotic disease of the vertebral and basilar arteries. J Neurosurg. 1993; 78: 192-198
    CrossrefPubMedGoogle Scholar
  • 28 Yadav JS, Roubin GS, King P. et al Angioplasty and stenting for restenosis after carotid endarterectomy. Initial Experience. Stroke 1996; 27: 2075-2079
    CrossrefPubMedGoogle Scholar
  • 29 Brown MM for the CAVATAS Investigators. Carotid and vertebral artery transluminal angioplasty study (CAVATAS) progress report. Cerebrovasc. Dis 1996; 6 (Suppl. 02) 34
    PubMedGoogle Scholar
  • 30 Cerebral Embolism Task Force. Cariogenic brain embolism. The second report of the cerebral embolism task force. Arch. Neurol. 1989; 46: 727-743
    CrossrefPubMedGoogle Scholar
  • 31 Hart RG, Halperin JL. Atrial fibrillation and stroke. Revisiting the dilemmas. Editorial Stroke 1994; 25: 1337-1341
    CrossrefPubMedGoogle Scholar
  • 32 Atrial Fibrillation Investigators.. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch.Intern. Med. 1994; 154: 1449-1457
    PubMedGoogle Scholar
  • 33 Stoke Prevention in Atrial Fibrillation Investigators. The stroke prevention in atrial fibrillation study. Final results. Circulation 1991; 84: 527-539
    CrossrefPubMedGoogle Scholar
  • 34 Ezekowits MD, Bridgers SL, Kenneth JE. et al Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. New Engl J Med 1992; 327: 1406-1412
    CrossrefPubMedGoogle Scholar
  • 35 The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. New Engl J Med 1990; 323: 1505-1511
    CrossrefPubMedGoogle Scholar
  • 36 The European Atrial Fibrillation Trial Study Group. Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. New Engl J Med 1995; 333: 05-10
    CrossrefPubMedGoogle Scholar
  • 37 Barnett HJM, Eliasziw M, and Meldrum HE. Drugs and surgery in the prevention of ischemic stroke. New Engl J Med 1995; 332: 238-248
    CrossrefPubMedGoogle Scholar
  • 38 Antiplatelet Trialists’ Collaboration. Collaborative overview of randomized trials of antiplatelet therapy I: Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308: 081-106
    CrossrefPubMedGoogle Scholar
  • 39 Steering Committee of the Physicians’ Health Study Research Group. Final report on the aspirin component of the ongoing physicians’ health study. New Engl J Med 1989; 321: 129-135
    CrossrefPubMedGoogle Scholar
  • 40 Peto R, Gray R, Collins R, et al. Randomized trial of prophylactic daily aspirin in British male doctors. BMJ 1988; 296: 313-316
    CrossrefPubMedGoogle Scholar
  • 41 Manson JE, Stampfer MJ, Golditz G, et al. A prospective study of aspirin use and primary prevention of cardiovascular disease in women. JAMA 1991; 266: 521-527
    CrossrefPubMedGoogle Scholar
  • 42 Hass WK, Easton JD, Adams HP, et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. New Engl J Med 1989; 321: 501-508
    CrossrefPubMedGoogle Scholar
  • 43 Schömig A, Neumann FJ, Kastrati A. et al A randomized comparison of Antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. New Engl J Med 1996; 334: 1084-1128
    CrossrefPubMedGoogle Scholar
  • 44 CAPRI Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischemic events. The Lancet 1996; 348: 1329-1339
    CrossrefPubMedGoogle Scholar
  • 45 Chimowitz MI, Kokkinos J, Strong J. et al The warfarin-aspirin symptomatic intracranial disease study. Neurology 1995; 45: 1488-1493
    CrossrefPubMedGoogle Scholar
  • 46 SPIRIT Study Group. Bleeding complications in patients after cerebral ischemia treated with anticoagulant drugs. Cerebrovas Dis 1996; 6 (Suppl. 02) 77
    PubMedGoogle Scholar
  • 47 Astrup J, Symon L, Siesjö BK. Thresholds in cerebral ischemia-the ischemic penumbr`6 Strojm. 1981; 12: 5@C-725
    PubMedGoogle Scholar
  • 48 Hossmann KA, Mid G, Paschen W. et al Multiparametric imaging blood flow and metabolism after middle cerebral artery occlusion in cats. J Cereb Blood Flow Metab 1985; 5: 097-107
    CrossrefPubMedGoogle Scholar
  • 49 Heiss WD, Huber M, Fink GR. et al Progressive derangement of periinfarct viable tissue in ischemic stroke. J Cereb Blood Flow Metab 1992; 12: 193-203
    CrossrefPubMedGoogle Scholar
  • 50 Hossmann KA. Viability thresholds and the penumbra of focal ischemia. Ann Neurol 1994; 36: 557-565
    CrossrefPubMedGoogle Scholar
  • 51 Lassen AN, Fieschi C, Lenzi GL. Ischemia penumbra and neuronal death: Comments on the therapeutic window in acute stroke with particular reference to thrombolytic therapy. Cerebrovas Dis 1991; 1 (Suppl. 01) 32-35
    CrossrefPubMedGoogle Scholar
  • 52 Kaplan B, Brint S, Tanabe J. et al Temporal thresholds for neo-cortical infarction in rats subjected to reversible focal cerebral ischemia. Stroke 1991; 22: 1032-1039
    CrossrefPubMedGoogle Scholar
  • 53 Jones TH, Morawetz RB, Crowell RM. et al Thresholds of focal cerebral ischemia in awake monkeys. J Neurosurg 1981; 54: 773-782
    CrossrefPubMedGoogle Scholar
  • 54 Grotta J. Rodent models of acute stroke – limitations. What have we learned from recent clinical trials of thrombolysis?. Arch Neurol 1996; 53: 1067-1070
    CrossrefPubMedGoogle Scholar
  • 55 Raichle ME. The pathophysiology of brain ischemia. Ann Neurol 1983; 13: 02-10
    CrossrefPubMedGoogle Scholar
  • 56 Wielock T, Harris RJ, Siesjö BK. Brain metabolism and ischemia: mechanism of cell damage and principals of protection. J Cereb Blood Flow Metab 1982; 2 (Suppl. 01) S5-S9
    PubMedGoogle Scholar
  • 57 Rothman S, Olney J. Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol 1986; 19: 105-111
    CrossrefPubMedGoogle Scholar
  • 58 DeGraba T, Ostrow P, Grotta J. Threshold of calcium disturbances after focal cerebral ischemia in rats -implications of the window of therapeutic opportunity. Stroke 1993; 24: 1212-1217
    CrossrefPubMedGoogle Scholar
  • 59 Matsushima K, Schmidt-Kastner R, Hakim AM. Genes and cerebral ischemia: Therapeutic perspectives. Cerebrovas Dis 1996; 6: 119-127
    CrossrefPubMedGoogle Scholar
  • 60 Feldmann E, Gordon N, Brooks J. et al Factors associated with early presentation of acute stroke. Stroke 1993; 24: 1805-1810.61
    CrossrefPubMedGoogle Scholar
  • 61 Bratina P, Greenberg L, Pasteur W, Grotta J. Current emergency department management of stroke in Houston, Texas. Stroke 1995; 26: 409-414
    CrossrefPubMedGoogle Scholar
  • 62 Kothari RU, Brott T, Broderick JP. et al Emergency physicians accuracy in the diagnosis of stroke. Stroke 1995; 26: 2238-2241
    CrossrefPubMedGoogle Scholar
  • 63 Pulsinelli WA, Levy DE, Sigsbee B. et al Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes. Am J Med 1983; 74: 540-544
    CrossrefPubMedGoogle Scholar
  • 64 Grotta JC, Pettigrew LC, Allen S. et al Baseline menodynamic state and response to hemodilution in patients with acute cerebral ischemia. Stroke 1985; 16: 790-795
    CrossrefPubMedGoogle Scholar
  • 65 The Hemodilution in Stroke Study Group: Hypervolemic hemodilution treatment of acute stroke: results of a randomized multicenter trial using pentastarch. Stroke 1989; 20: 317-323
    CrossrefPubMed
  • 66 Wallace JD, Levy LL. Blood pressure after stroke. JAMA 1981; 246: 2177-2180
    CrossrefPubMedGoogle Scholar
  • 67 Strandgaard S, Paulson OB. Cerebral blood flow and its pathophysiology. Am J Hypertension 1989; 2: 486-492
    CrossrefPubMedGoogle Scholar
  • 68 Lisk DR, Grotta JC, Lamik LM. et al Should hypertension be treated after acute stroke? A randomized controlled trial using single photon emission computed tomography. Arch Neurol 1993; 50: 855-862
    CrossrefPubMedGoogle Scholar
  • 69 Busto R, Globus M, Dietrich D. et al Effect of mild hypothermia on ischemia-induced release of neurotransmitter and free fatty acids in rat brain. Stroke 1989; 20: 904-910
    CrossrefPubMedGoogle Scholar
  • 70 Reith J, Jorgensen HS, Pedersen PM. et al Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome. The Lancet 1996; 347: 422-425
    CrossrefPubMedGoogle Scholar
  • 71 Naritomi H, Shimizu T, Oe H. et al Mild hypothermia therapy in acute embolic stroke: a pilot study. J Stroke and Cerbrovasc Dis 1996; 6 (Suppl. 01) 193-196
    PubMedGoogle Scholar
  • 72 Clifton GL, Allen S, Barrodale P. et al A phase II study of moderate hypothermia in severe brain injury. Journal of Neurotrauma 1993; 10: 263-271
    CrossrefPubMedGoogle Scholar
  • 73 Duke RJ, Blocj RF, Turpie AG. et al Intravenous heparin for the prevention of stroke progression in acute partial stable stroke. Ann Int Med 1986; 105: 825-828
    CrossrefPubMedGoogle Scholar
  • 74 Toni D, Fiorelli M, Bastianello S. et al Hemorrhagic transformation of brain infarct: predictability in the first 5 hours from stroke onset and influence on clinical outcome. Neurology 1996; 46: 341-345
    CrossrefPubMedGoogle Scholar
  • 75 Kay R, Wong KS, Yu YL. et al Low-molecular-weight heparin for the treatment of acute ischemic stroke. New Engl J Med 1995; 333: 1588-1593
    CrossrefPubMedGoogle Scholar
  • 76 The International Stroke Trial Collaborative Group. The international stroke trial. Preliminary results, part 1: Effects of aspirin and heparin separately and in combination. Cerebrovasc Dis 1996; 6 (Suppl. 02) 23
    PubMedGoogle Scholar
  • 77 Chen ZM, Xie JX, Peto R. et al Chinese acute stroke trial (CAST): Rationale, design and progress. Cerebrovasc Dis 1996; 6 (Suppl. 02) 23
    PubMedGoogle Scholar
  • 78 Candelise L, Motto C, Aritzu E. et al Aspirin given within 6 hours reduces long term case fatality but not stroke related disability. Cerebrovasc Dis 1996; 6 (Suppl. 02) 23-24
    PubMedGoogle Scholar
  • 79 Adams HP, Brott TG, Furlan AJ. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the stroke council, American Heart Association. Circulation 1996; 94: 1167-1174
    CrossrefPubMedGoogle Scholar
  • 80 American Heart Association Quality Standards Subcommittee. Practice Advisory: Thrombolytic therapy for acute ischemic stroke – summary statement. Neurology 1996; 47: 835-839
    CrossrefPubMedGoogle Scholar
  • 81 The National Institute of Neurological Disorders and Stroke rt-tPA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. New Engl J Med 1995; 333: 1581-1587
    CrossrefPubMedGoogle Scholar
  • 82 Multicentre Acute Stroke Trial – Italy (MAST-I) Group. Randomized controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischemic stroke. The Lancet 1995; 346: 1509-1515
    CrossrefPubMedGoogle Scholar
  • 83 The Multicenter Acute Stroke Trial – Europe Study Group. Thrombolytic therapy with streptokinase in acute ischemic stroke. New Engl J Med 1996; 335: 145-150
    CrossrefPubMedGoogle Scholar
  • 84 Donnan GA, Davis SM, Chambers BR. et al Trials of streptokinase in severe acute ischemic stroke. The Lancet 1995; 345: 578-579
    CrossrefPubMedGoogle Scholar
  • 85 The European Cooperative Acute Stroke Study (ECASS). Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. JAMA 1995; 274: 1017-1025
    CrossrefPubMedGoogle Scholar
  • 86 Fletcher AP, Alkjaersig N, Lewis M. et al A pilot study of urokinase therapy in cerebral infarction. Stroke 1976; 7: 135-142
    CrossrefPubMedGoogle Scholar
  • 87 Meyer JS, Gilroy J, Barnhart J. Therapeutic thrombolysis in cerebral thromboembolism: randomized evaluation of intravenous streptokinase. In Siekert W, Whisnant JP. eds Cerebral Vascular Diseases. New York: Grune & Stratton; 1965: 200-213
    Google Scholar
  • 88 The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. New Engl J Med 1993; 329: 673-682
    CrossrefPubMedGoogle Scholar
  • 89 Sussman BJ, Fitch TSP. Thrombolysis with fibrinolysin in cerebral arterial occlusion. JAMA 1958; 167: 1705-1709
    CrossrefPubMedGoogle Scholar
  • 90 Brott TG, Haley EC, Levy DE. et al Urgent therapy for stroke I. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke 1992; 23: 632-640
    CrossrefPubMedGoogle Scholar
  • 91 Haley EC, Levy DE, Brott TG. et al Urgent therapy for stroke.II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset. Stroke 1992; 23: 641-645
    CrossrefPubMedGoogle Scholar
  • 92 Haley EC, Brott TG, Sheppard GL. et al Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. Stroke 1993; 24: 1000-1004
    CrossrefPubMedGoogle Scholar
  • 93 Mori E, Yoneda Y, Tabuchi M. et al Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology 1992; 42: 976-982
    CrossrefPubMedGoogle Scholar
  • 94 The Japanese Thrombolysis Study Group. Intravenous tissue plasminogen activator in acute thromboembolic stroke: A placebo-controlled, double-blind trial. In del Zoppo GJ, Mori E, Hacke W. eds Thrombolytic Therapy in Acute Ischemic Stroke II. Berlin Heidelberg; Springer- Verlag 1993; 59-65
    PubMedGoogle Scholar
  • 95 del Zoppo GJ, Poeck K, Pessin MS. et al Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992; 32: 78-86
    CrossrefPubMedGoogle Scholar
  • 96 Fagan S, Morgenstern L, Petita A. et al rtPA reduces length of stay and improves disposition following stroke. Stroke. (in press).
    Google Scholar
  • 97 del Zoppo GJ, Higashida RT, Furlan AJ. et al The prolyse in acute cerebral thromboembolism trial (PROACT): results of 6 mg dose tier. Stroke 1996; 27: 164
    PubMedGoogle Scholar
  • 98 The Ancrod Stroke Study Investigators. Ancrod for the treatment of acute ischemic brain infarction. Stroke 1994; 25: 1755-1759
    CrossrefPubMedGoogle Scholar
  • 99 Allen GS, Ahn HS, Preziosi TJ. et al Cerebral arterial spasm -a controlled trial of nimodipine in patients with subarachnoid hemorrhage. New Engl J Med 1983; 308: 619-624
    CrossrefPubMedGoogle Scholar
  • 100 Pickard JD, Murray GD, Illingworth R. et al Effect of oral nimidipine on cerebral infarction and outcome after subarachnoid hemorrhage: British Aneurysm Nimodipine Trial. Brit Med J 1989; 298: 636-642
    CrossrefPubMedGoogle Scholar
  • 101 The American Nimodipine Study Group. Clinical trial of nimodipine in acute ischemic stroke. Stroke 1992; 22: 3-8
    PubMedGoogle Scholar
  • 102 Mohr JP, Orgogozo J, Harrison M. et al Meta-analysis of oral nimodipine trials in acute ischemic stroke. Cerebrovasc Dis 1994; 4: 197-203
    CrossrefPubMedGoogle Scholar
  • 103 The Lubeluzole International Study Group. Lubeluzole in acute ischemic stroke: a double-blind, placebo-controlled phase II trial. Stroke 1996; 27: 76-81
    CrossrefPubMedGoogle Scholar
  • 104 The LUB-INT-9 Lubeluzole Study Group. The efficacy and safety of Lubeluzole in patients with acute ischemic stroke. Stroke. 1996. (in press).
    Google Scholar
  • 105 Grotta JC, Clark W, Coull B. et al Safety and tolerability of the glutamate antagonist CGS 19755 (selfotel) in patients with acute ischemic stroke. Results of a phase IIa randomized trial. Stroke 1995; 26: 602-605
    CrossrefPubMedGoogle Scholar
  • 106 Albers GW, Atkinson RP, Kelley RE. et al Safety, tolerability, and pharmacokinetics of the N-methyl-D-aspartate antagonist dextrophan in patients with acute stroke. Stroke 1995; 26: 254-258
    CrossrefPubMedGoogle Scholar
  • 107 The CNS 1102-008 Study Group. Cerestat (aptiganel hydrochloride) in the treatment of acute ischemic stroke: results of a phase II trial. Neurology 1996; 46: A424
    PubMedGoogle Scholar
  • 108 Clark WM, Coull BM, Karukin M. et al Randomized trial of cervene, a K receptor-selective opioid antagonist, in acute ischemic stroke. Stroke and Cerebrovasc Dis 1996; 6: 35-40
    PubMedGoogle Scholar
  • 109 Tietjen GE, Dombi T, Pulsinelli WA. et al A double-blind, safety and tolerance study of single intravenous doses of fosphenytoin in patients with acute ischemic stroke. Neurology 1996; 46: A424
    PubMedGoogle Scholar
  • 110 Yang G, Betz L. Reperfusion-induced injury to the blood-brain barrier after middle cerebral artery occlusion in rats. Stroke 1994; 25: 1658-1665
    CrossrefPubMedGoogle Scholar
  • 111 Kassell NF, Haley EC, Hansen C. et al Randomized, doubleblind, vehicle controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: A cooperative study in Europe, Australia, and New Zealand. J Neurosurg 1996; 84: 221-228
    CrossrefPubMedGoogle Scholar
  • 112 The RANTTAS Investigators. A randomized trial of tirilazad mesylate in patients with acute stroke. Stroke 1996; 27: 1455-1458
    PubMedGoogle Scholar
  • 113 Sariano SG, Lipton SA, Wang YF. et al Intercellular adhesion molecule-1-deficient mice are less susceptible to cerebral ischemia-Reperfusion injury. Ann Neurol 1996; 39: 618-624
    CrossrefPubMedGoogle Scholar
  • 114 Kirschner PB, Henshaw R, Weise J. et al Basic fibroblast growth factor protects against excitotoxicity and chemical hypoxia in both neonatal and adult rats. J Cereb Blood Flow Metab 1995; 15: 619-623
    CrossrefPubMedGoogle Scholar
  • 115 Clark WM, and Warach SJ. Randomized dose response trial of citicoline in acute ischemic stroke patients. Neurology 1996; 46 A 425
    CrossrefPubMedGoogle Scholar
  • 116 Heros RC. Surgical treatment of cerebellar infarction. Stroke 1992; 23: 937-938
    CrossrefPubMedGoogle Scholar
  • 117 Forsting M, Reith W, Schabitz WR. et al Decompressive craniectomy for cerebral infarction. An experimental study in rats. Stroke 1995; 26: 259-264
    CrossrefPubMedGoogle Scholar
  • 118 Rieke K, Schwab St, Krieger D. et al Decompressive surgery in space-occupying hemispheric infarction: results of an open, prospective trial. Critical Care Medicine 1995; 23: 1576-1587
    CrossrefPubMedGoogle Scholar
  • 119 Jorgensen HS, Nakayama H, Rasschou HO. et al The effect of a stroke unit: Reductions in mortality, discharge rate to nursing home, length of hospital stay, and cost. A community-based study. Stroke 1995; 26: 1178-1182
    CrossrefPubMedGoogle Scholar
  • 120 Wentworth DA, and Atkinson RP. Implementation of an acute stroke program decreases hospitalization costs and length of stay. Stroke 1996; 27: 1040-1043
    CrossrefPubMedGoogle Scholar
  • 121 Mitchell J, Bollard D, Whisnant J, Ammering C, Samsa G, Matchar D. What role do neurologists play in determining the costs and outcomes of stroke patients?. Stroke 1996; 27: 1937-1943
    CrossrefPubMedGoogle Scholar
  • 122 Kalra L. The influence of stroke unit rehabilitation on functional recovery from stroke. Stroke 1994; 25: 821-825
    CrossrefPubMedGoogle Scholar
  • 123 Karbe H, Thiel A, Weber-Luxemburger G. et al Post-stroke aphasia: How does the brain cope with the functional impairment. Cerebrovasc Dis 1996; 6 (Suppl. 02) 17
    CrossrefPubMedGoogle Scholar
  • 124 Frackowiak RSJ. Plasticity and the human brain: insights from functional imaging. Neuroscientist 1996; 2: 353-362
    CrossrefPubMedGoogle Scholar
  • 125 Nudo RJ, Wise BM, Si Fuentes. et al Neural substrates for the effects of rehabilitative training on motor recovery after ischemic infarct. Science 1996; 272: 1791-1794
    CrossrefPubMedGoogle Scholar
  • 126 Koslowski DA, James DC, Schallert T. Use-dependent exaggeration of neuronal injury after unilateral sensorimotor cortex lesions. J Neuroscience 1996; 16: 4776-4786
    CrossrefPubMedGoogle Scholar
  • 127 Johansson K, Lindgren I, Widner H. et al Can sensory stimulation improve the functional outcome in stroke patients?. Neurology 1993; 43: 2189-2192
    CrossrefPubMedGoogle Scholar
  • 128 Walker-Batson D, Smith P, Curtis S. et al Amphetamine paired with physical therapy accelerates motor recovery after stroke. Further evidence. Stroke 1995; 26: 2254-2259
    CrossrefPubMedGoogle Scholar
  • 129 Bhakta BB, Cozens JA, Bamford JM. et al Use of botulinum toxin in stroke patients with severe upper limb spasticity. JNNP 1996; 61: 30-35
    PubMedGoogle Scholar
  • 130 Simpson DM, Alexander DN, O’Brien CF. et al Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial. Neurology 1996; 46: 1306-1310
    CrossrefPubMedGoogle Scholar
  • 131 Penn RD, Savoy SM, Corcos D. et al Intrathecal baclofen for severe spinal spasticity. New Engl J Med 1989; 320: 1517-1521
    CrossrefPubMedGoogle Scholar
  • 132 Awad IA, Carter LP, Spetzler RF. et al Clinical vasospasm after subarachnoid hemorrhage: response to hypervolemic hemodilution and arterial hypertension. Stroke 1987; 18: 365-372
    CrossrefPubMedGoogle Scholar
  • 133 Guglielmi G, Vinuela F, Sepetka E. et al Electrothrombosis of saccular aneurysms via endovascular approach. Part 1. electrochemical basis, technique, and experimental results. J Neurosurg 1991; 75: 1-7
    CrossrefPubMedGoogle Scholar
  • 134 Guglielmi G, Vinuela F, Dion J. et al Electrothrombosis of saccular aneurysms via endovascular approach. Part 2. preliminary clinical experience. J Neurosurg 1991; 75: 08-14
    CrossrefPubMedGoogle Scholar
  • 135 Casaco AE, Aymard A, Gobin YP. et al Selective endovascular treatment of 71 intracranial aneurysms with platinum coils. J Neurosurg 1993; 79: 03-10
    CrossrefPubMedGoogle Scholar
  • 136 Guglielmi G, Vinuela F, Duckwiler G. et al Endovascular treatment of posterior circulation aneurysms by electrothrombosis using electrically detachable coils. J Neurosurg 1992; 77: 515-524
    CrossrefPubMedGoogle Scholar
  • 137 Lunsford LD, Kondziolka D, Flickinger JC. et al Sterotactic radiosurgery for arteriovenous malformations of the brain. J Neurosurg 1991; 75: 512-524
    CrossrefPubMedGoogle Scholar
  • 138 Broderick J, Brott T, Tomskick T. et al Management of intracerebral hemorrhage in a large metropolitan population. Neurosurgery 1994; 34: 882-887
    PubMedGoogle Scholar
  • 139 Kaneko J, Tanaka K, Shimada T. et al Long term evaluation of ultra-early operation for hypertensive intracerebral hemorrhage in 100 cases. J Neurosurg 1983; 58: 838-842
    CrossrefPubMedGoogle Scholar
  • 140 Niizuma H, Shimuzu Y, Yonemitsu T. et al results of stereotactic aspiration in cases of putaminal hemorrhage. Neurosurg 1989; 24: 814-819
    CrossrefPubMedGoogle Scholar
  • 141 Auer L, Deinsberger W, Niederkom K. et al Endoscopic surgery vs. medical treatment for spontaneous intracerebral hematoma: a randomized study. J Neurosurg 1989; 70: 530-535
    CrossrefPubMedGoogle Scholar
  • 142 Juvela S, Heiskanes O, Proanen A. et al The treatment of spontaneous intracerebral hemorrhage. A prospective randomized trial of surgical and conservative treatment. J Neurosurg 1989; 70: 755-758
    CrossrefPubMedGoogle Scholar
  • 143 Batjer H, Reisch J, Allen B. et al Failure of surgery to improve outcome in hypertensive putaminal hemorrhage. A prospective randomized trial. Arch Neurol 1990; 47: 1103-1106
    CrossrefPubMedGoogle Scholar
  • 144 Kandel El, Peresedov VV. Stereotaxic evacuation of spontaneous intracerebral hematomas. J Neurosurg 1990; 54: 427-431
    PubMedGoogle Scholar
  • 145 Grotta J, Morgenstem L, Shedden P. et al Randomized trial of early surgery for hemispheric intracerebral hemorrhage. Cerebrovasc Dis 1996; 6 (Suppl. 02) 21
    CrossrefPubMedGoogle Scholar
  • 146 Brott T, Broderick J, Barson W. et al Continued bleeding during the first hours of intracerebral hemorrhage. Ann Neurol 1994; 36: 330
    PubMedGoogle Scholar
  • 147 Mendelow A. Mechanisms of ischemic brain damage with intracerebral hemorrhage. Stroke 1993; 24: 1115-1117
    CrossrefPubMedGoogle Scholar
  • 148 Nehls G, Major M, Mendelow D. et al Experimental intracerebral hemorrhage: progression of hemodynamic changes after production of a spontaneous mass lesion. Neurosurg 1988; 23: 439-444
    CrossrefPubMedGoogle Scholar
  • 149 Wagner K, Ghuhua X, Hua Y. et al Lobar intracerebral hemorrhage model in pigs: Rapid edema development in perihematomal white matter. Stroke 1996; 27: 490-497
    CrossrefPubMedGoogle Scholar
  • 150 Wagner K, Ghuhua X, Hua Y. et al White matter edema in experimental lobar intracerebral hemorrhage. Stroke 1995; 26: 178
    PubMedGoogle Scholar
  • 151 Sills C, Villar-Cordova C, Pasteur W. et al Demonstration of hypoperfusion surrounding intracerebral hematoma in Humans. Journal Stroke and Cerebrovas Dis 1996; 6: 17-24
    PubMedGoogle Scholar